GB1290141A - - Google Patents
Info
- Publication number
- GB1290141A GB1290141A GB1290141DA GB1290141A GB 1290141 A GB1290141 A GB 1290141A GB 1290141D A GB1290141D A GB 1290141DA GB 1290141 A GB1290141 A GB 1290141A
- Authority
- GB
- United Kingdom
- Prior art keywords
- vaccines
- toxoid
- welchii
- polyornithine
- polyarginine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 229960005486 vaccine Drugs 0.000 abstract 3
- 230000000890 antigenic effect Effects 0.000 abstract 2
- 239000000463 material Substances 0.000 abstract 2
- 206010035664 Pneumonia Diseases 0.000 abstract 1
- 108010039918 Polylysine Proteins 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 239000002671 adjuvant Substances 0.000 abstract 1
- 125000003277 amino group Chemical group 0.000 abstract 1
- 230000001580 bacterial effect Effects 0.000 abstract 1
- 244000309466 calf Species 0.000 abstract 1
- 229960003983 diphtheria toxoid Drugs 0.000 abstract 1
- 230000001717 pathogenic effect Effects 0.000 abstract 1
- 229920000724 poly(L-arginine) polymer Polymers 0.000 abstract 1
- 108010011110 polyarginine Proteins 0.000 abstract 1
- 229920000656 polylysine Polymers 0.000 abstract 1
- 108010055896 polyornithine Proteins 0.000 abstract 1
- 229920002714 polyornithine Polymers 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 229960000814 tetanus toxoid Drugs 0.000 abstract 1
- 230000003612 virological effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55516—Proteins; Peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2611568 | 1968-05-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1290141A true GB1290141A (enrdf_load_html_response) | 1972-09-20 |
Family
ID=10238613
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB1290141D Expired GB1290141A (enrdf_load_html_response) | 1968-05-31 | 1968-05-31 |
Country Status (1)
| Country | Link |
|---|---|
| GB (1) | GB1290141A (enrdf_load_html_response) |
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0038153A3 (en) * | 1980-04-15 | 1982-12-22 | Beecham Group Plc | Modified allergens |
| FR2577139A1 (fr) * | 1985-02-10 | 1986-08-14 | Israel Mini Agricult | Composition de vaccin et mode de sa preparation |
| DE19638313A1 (de) * | 1996-09-19 | 1998-04-02 | Boehringer Ingelheim Int | Pharmazeutische Zusammensetzung für die Immunmodulation |
| US6166217A (en) * | 1998-02-09 | 2000-12-26 | Alliedsignal Inc. | Process for the production of alkoxycarbonyldipeptides intermediates in the synthesis of the lisinopril |
| WO2000056361A3 (en) * | 1999-03-24 | 2001-03-01 | Secr Defence | Vaccine composition |
| AT408721B (de) * | 1999-10-01 | 2002-02-25 | Cistem Biotechnologies Gmbh | Pharmazeutische zusammensetzung enthaltend ein antigen |
| WO2002053185A3 (en) * | 2001-01-05 | 2002-10-31 | Intercell Biomedizinische Forschungs & Entwicklungs Gmbh | Anti-inflammatory use of polycationic compounds |
| US7105162B1 (en) | 1996-02-24 | 2006-09-12 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition for immunomodulation based on peptides and adjuvants |
| US7244438B2 (en) | 2001-01-05 | 2007-07-17 | Intercell Ag | Uses for polycationic compounds |
| US20170014350A1 (en) * | 2015-07-16 | 2017-01-19 | University-Industry Foundation, Yonsei University | Oral virus vaccine |
-
1968
- 1968-05-31 GB GB1290141D patent/GB1290141A/en not_active Expired
Cited By (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0038153A3 (en) * | 1980-04-15 | 1982-12-22 | Beecham Group Plc | Modified allergens |
| FR2577139A1 (fr) * | 1985-02-10 | 1986-08-14 | Israel Mini Agricult | Composition de vaccin et mode de sa preparation |
| US7105162B1 (en) | 1996-02-24 | 2006-09-12 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition for immunomodulation based on peptides and adjuvants |
| DE19638313A1 (de) * | 1996-09-19 | 1998-04-02 | Boehringer Ingelheim Int | Pharmazeutische Zusammensetzung für die Immunmodulation |
| DE19638313C2 (de) * | 1996-09-19 | 2000-05-31 | Boehringer Ingelheim Int | Pharmazeutische Zusammensetzung für die Immunmodulation |
| US6166217A (en) * | 1998-02-09 | 2000-12-26 | Alliedsignal Inc. | Process for the production of alkoxycarbonyldipeptides intermediates in the synthesis of the lisinopril |
| AU762078B2 (en) * | 1999-03-24 | 2003-06-19 | Secretary Of State For Defence, The | Vaccine composition |
| WO2000056361A3 (en) * | 1999-03-24 | 2001-03-01 | Secr Defence | Vaccine composition |
| AT408721B (de) * | 1999-10-01 | 2002-02-25 | Cistem Biotechnologies Gmbh | Pharmazeutische zusammensetzung enthaltend ein antigen |
| EP2269640A2 (en) | 1999-10-01 | 2011-01-05 | Intercell AG | Hcv vaccine compositions |
| EP2269641A2 (en) | 1999-10-01 | 2011-01-05 | Intercell AG | Hcv vaccine compositions |
| EP2269642A2 (en) | 1999-10-01 | 2011-01-05 | Intercell AG | Hcv vaccine compositions |
| EP2269643A2 (en) | 1999-10-01 | 2011-01-05 | Intercell AG | Hcv vaccine compositions |
| US8277815B2 (en) | 1999-10-01 | 2012-10-02 | Intercell Ag | Pharmaceutical composition comprising an antigen |
| WO2002053185A3 (en) * | 2001-01-05 | 2002-10-31 | Intercell Biomedizinische Forschungs & Entwicklungs Gmbh | Anti-inflammatory use of polycationic compounds |
| US7244438B2 (en) | 2001-01-05 | 2007-07-17 | Intercell Ag | Uses for polycationic compounds |
| US20170014350A1 (en) * | 2015-07-16 | 2017-01-19 | University-Industry Foundation, Yonsei University | Oral virus vaccine |
| US10136662B2 (en) * | 2015-07-16 | 2018-11-27 | University-Industry Foundation, Yonsei University | Oral virus vaccine |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1290141A (enrdf_load_html_response) | ||
| GB1502774A (en) | Immunological preparations | |
| ES408766A1 (es) | Procedimiento para preparar agentes inmunologicos. | |
| LU91596I2 (fr) | Combinaison d'anatoxine diphtérique, d'anatoxine tétanique,d'antoxine coquelucheuse, d'hémagglutinine filamenteuse, de pertactine, de virus poliomyélitique inactivé type 1, type 2 et type 3 et de polyoside capsulaire d'haemophilus influenzae type b (Infanrix - IPV/Hib) | |
| GB1422973A (en) | Process for preparing adsorbed vaccines | |
| SE324208B (enrdf_load_html_response) | ||
| GB1292803A (en) | Improvements relating to the production of antigens | |
| GB1256456A (en) | Ethylethyleneimine as inactivating agent in antigen-containing pharmaceutical preparations | |
| JPS5527178A (en) | Live influenza virus vaccine | |
| GB1413614A (en) | Virus production | |
| JPS5576819A (en) | Attenuated feline infectious peritonitis virus | |
| OA09863A (en) | Use of IL-4 to enhance immune response to immunogens in vaccines. | |
| GB1256457A (en) | Diethylaminoethyldextran (deae-d) as adjuvant for vaccines for active immunisation | |
| IE40221B1 (en) | Influenza vaccines | |
| ZA805849B (en) | Process for the preparation of novel influenza virus strains and influenza virus vaccines containing them | |
| GB1399782A (en) | Vaccines for immunization against kennel cough | |
| GB1089767A (en) | Vaccine adjuvants | |
| ES8107300A1 (es) | Un metodo para la preparacion de una composicion de virus herpes | |
| GB1436323A (en) | Cell and virus culture systems | |
| GB1449606A (en) | Vaccine preparation | |
| GB1498821A (en) | Vaccines | |
| GB1439742A (en) | Live influenza type b virus vaccines and preparation thereof | |
| GR3020495T3 (en) | Two-phase system for the production and presentation of foreign antigens in hybrid live vaccines | |
| GB1267591A (en) | Antigenic materials | |
| FR2047886A1 (en) | Non-toxic anti-whooping cough vaccine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed | ||
| PCNP | Patent ceased through non-payment of renewal fee |